{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/66475af9e1c79600121736a4/6a4429606771af4aa40e6176?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"#172 Decoding Longevity Medicine: Precision Care, Peptides, and Practical Wellness with HUM2N Founder Dr Mohammed Enayat","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/66475af9e1c79600121736a4/1782851904268-02ac01de-15ef-4054-9f15-341dea6dc68b.jpeg?height=200","description":"<p>Today Adrienne is joined by <a href=\"https://www.instagram.com/bydr.e/?hl=en\" rel=\"noopener noreferrer\" target=\"_blank\">Dr Mohammed Enayat</a>, a London-trained GP and founder of <a href=\"https://www.hum2n.com/\" rel=\"noopener noreferrer\" target=\"_blank\">HUM2N</a>, a physician-led longevity and personalised medicine clinic, to discuss his shift from reactive, organ-based healthcare toward functional “root cause” and longevity/precision medicine using richer diagnostics. </p><p><br></p><p>They explore how wellness has become mainstream, what people really mean by “longevity”, and how HUM2N integrates traditional care with functional medicine, advanced therapies, and specialist networks. The conversation covers peptides (licensed options like GLP-1s versus unlicensed, unregulated products) emphasising risks, self-dosing concerns, and the need for physician oversight, screening, and ongoing biomarker monitoring. </p><p><br></p><p>They also discuss the future of luxury wellness and hospitality moving toward safer, medically guided programmes with diagnostics and follow-up, plus accessible daily habits like cardio and strength training, chewing food, hydration, and timing meals.</p><p><br></p><p><br></p>","author_name":"Adrienne Adhami, Sammi Adhami, Oli Patrick"}